Inventor · disambiguated record
Jason John Shiers
Also filed as: SHIERS JASON · SHIERS JASON J · SHIERS JASON JOHN
9 granted patents·6 pending applications·2 citations·filing 2003–2024
76Inventor score
Files withGREY WOLF THERAPEUTICS LTD6BERGENBIO ASA3CARRICK THERAPEUTICS LTD2CORCORAN JONATHAN PATRICK THOMAS1GRUENENTHAL GMBH1
Top patents by PatentIndex Score
15 records- 0170US9447028B2Therapeutic aryl-amido-aryl compounds and their useKING S COLLEGE LONDON·Filed 2015·Granted Sep 20, 2016·1 cites·20 claims
- 0269US10336702B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2015·Granted Jul 2, 2019·1 cites·28 claims
- 0367US2024366595A1Phenyl-sulfamoyl.benzoyc acids as erap1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0463US10766861B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2019·Granted Sep 8, 2020·0 cites·9 claims
- 0562US2021070708A1Pharmaceutically Active CompoundsBERGENBIO ASA·Filed 2020·Application pending·0 cites
- 0656US2024376046A1Phenyl-sulfamoyl-benzoic acid derivatives as erap1- modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0752US12023333B2Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2020·Granted Jul 2, 2024·0 cites·11 claims
- 0849US11857552B24-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitorsCARRICK THERAPEUTICS LTD·Filed 2018·Granted Jan 2, 2024·0 cites·6 claims
- 0949US2024300976A1Compounds as modulators of endoplasmic reticulum aminopeptidase 1 (erap1)GREY WOLF THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1047US12377084B2ERAP1 modulatorsGREY WOLF THERAPEUTICS LTD·Filed 2020·Granted Aug 5, 2025·0 cites·20 claims
- 1144US12485169B2CompoundsGREY WOLF THERAPEUTICS LTD·Filed 2019·Granted Dec 2, 2025·0 cites·11 claims
- 1242US2012149737A1Therapeutic Aryl-Amido-Aryl Compounds and Their UseCORCORAN JONATHAN PATRICK THOMAS·Filed 2010·Application pending·0 cites
- 1341US2004045783A1Wheel hub with clutchFiled 2003·Application pending·0 cites
- 1439US12473303B24-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino methyl]piperidin-3-ol compounds and their therapeutic useCARRICK THERAPEUTICS LTD·Filed 2020·Granted Nov 18, 2025·0 cites·20 claims
- 1534US9670189B2Substituted condensed pyrimidine compoundsGRUENENTHAL GMBH·Filed 2015·Granted Jun 6, 2017·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →